אבוסינאגיס 100 מ"ג

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

PALIVIZUMAB 100 MG

Verfügbar ab:

ABBVIE BIOPHARMACEUTICALS LTD, ISRAEL

ATC-Code:

J06BB16

Darreichungsform:

POWDER FOR SOLUTION FOR INJECTION

Verabreichungsweg:

I.M

Hergestellt von:

ABBVIE S.R.L., ITALY

Therapiegruppe:

PALIVIZUMAB

Anwendungsgebiete:

Is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV). Safety and efficacy were established in infants with bronchopulmonary dysplasia (BPD) and in infants with a history of prematurity (35 weeks gestational age) and in children less then 2 years of age,with haemodynamically significant congenital heart disease.

Berechtigungsdatum:

2010-06-01